RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Losartan Reduces Aortic Dilatation Rate in Adults with Marfan Syndrome
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 15
SP 15
OP 16
DO 10.1177/155989771315010
UL http://mdc.sagepub.com/content/13/15/15.abstract
AB Results from the Cozaar in Marfan Patients Reduces Aortic Enlargement trial [COMPARE; Groenink M et al. Eur Heart J 2013] demonstrated that the angiotensin receptor blocker, losartan, significantly reduced the rate of aortic enlargement after 3 years in patients with Marfan syndrome.